FI3442956T3 - Menetelmä pyrviniumpamoaatin ja sen kiteisten muotojen valmistamiseksi - Google Patents

Menetelmä pyrviniumpamoaatin ja sen kiteisten muotojen valmistamiseksi Download PDF

Info

Publication number
FI3442956T3
FI3442956T3 FIEP17717678.1T FI17717678T FI3442956T3 FI 3442956 T3 FI3442956 T3 FI 3442956T3 FI 17717678 T FI17717678 T FI 17717678T FI 3442956 T3 FI3442956 T3 FI 3442956T3
Authority
FI
Finland
Prior art keywords
crystalline form
formula
form iii
pyrvinium pamoate
pamoate salt
Prior art date
Application number
FIEP17717678.1T
Other languages
English (en)
Finnish (fi)
Inventor
Río Pericacho José Luis Del
Via Josep Martí
Paredes Antonio De Padua Cánovas
Original Assignee
Urquima Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urquima Sa filed Critical Urquima Sa
Application granted granted Critical
Publication of FI3442956T3 publication Critical patent/FI3442956T3/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FIEP17717678.1T 2016-04-13 2017-04-12 Menetelmä pyrviniumpamoaatin ja sen kiteisten muotojen valmistamiseksi FI3442956T3 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16382169.7A EP3231796A1 (en) 2016-04-13 2016-04-13 A process for the preparation of pyrvinium pamoate and crystalline forms thereof
PCT/EP2017/058773 WO2017178524A1 (en) 2016-04-13 2017-04-12 A process for the preparation of pyrvinium pamoate and crystalline forms thereof

Publications (1)

Publication Number Publication Date
FI3442956T3 true FI3442956T3 (fi) 2024-05-03

Family

ID=55809063

Family Applications (1)

Application Number Title Priority Date Filing Date
FIEP17717678.1T FI3442956T3 (fi) 2016-04-13 2017-04-12 Menetelmä pyrviniumpamoaatin ja sen kiteisten muotojen valmistamiseksi

Country Status (5)

Country Link
EP (2) EP3231796A1 (enExample)
JP (1) JP7021107B2 (enExample)
ES (2) ES2689371B1 (enExample)
FI (1) FI3442956T3 (enExample)
WO (1) WO2017178524A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12447147B2 (en) 2019-10-22 2025-10-21 Thomas Jefferson University Methods of treating, ameliorating, and/or preventing cancer using pyrvinium compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2515912A (en) * 1946-10-01 1950-07-18 Eastman Kodak Co Pyrrole dimethinecyanine dyes
BE572031A (enExample) 1957-11-06
JP2008527047A (ja) * 2005-01-18 2008-07-24 イミューソル インコーポレイテッド 新規キノリニウム塩及び誘導体

Also Published As

Publication number Publication date
BR112018071009A2 (pt) 2019-02-12
JP7021107B2 (ja) 2022-02-16
EP3231796A1 (en) 2017-10-18
WO2017178524A1 (en) 2017-10-19
ES2689371A8 (es) 2018-12-05
ES2689371B1 (es) 2019-08-22
ES2689371A1 (es) 2018-11-13
EP3442956A1 (en) 2019-02-20
JP2019511523A (ja) 2019-04-25
ES2977432T3 (es) 2024-08-23
EP3442956B1 (en) 2024-03-27

Similar Documents

Publication Publication Date Title
JP6986045B2 (ja) キナーゼを修飾する1h−ピロロ[2,3−b]ピリジン誘導体の合成
SI2428519T1 (sl) Sestavek za pripravo 17-vinil-triflatov kot intermediatov
ES2587903T3 (es) Compuestos de imidazolidinadiona y sus usos
RU2018121988A (ru) EMM-28-новый синтетический кристаллический материал, его получение и применение
BR112018073348B1 (pt) Métodos para preparar 6-aril-4-aminopicolinatos e 2-aril-6- aminopirimidina-4-carboxilatos por acoplamento direto de suzuki
RU2010152758A (ru) Кристаллическая форма и тозилат соединения тетрациклина, кристаллическая форма указанного тозилата и ее полиморфная модификация, способ получения тозилата соединения тетрациклина, полиморфная модификация, полученная указанным способом, и фармацевтические композиции на основе вышеуказанных кристаллической формы и полиморфной модификации
RU2014110400A (ru) Способ и промежуточные соединения для получения макролактамов
JO3098B1 (ar) مركبات داي فينيل- بيرازول بيريدين وطريقة تحضيرها واستخدامها كمعدلات المستقبل النووي not
EA200800886A1 (ru) Способ получения 1-н-имидазо[4,5-с]пиридинов и их аналогов
NZ734535A (en) Process of producing cycloalkylcarboxamido-indole compounds
AR083213A1 (es) Proceso de preparacion de derivados pirimidinicos, compuestos intermediarios y proceso para prepararlos
JP6948952B2 (ja) 均一系触媒によるカルボニル化合物の還元的アミノ化法
WO2009154754A3 (en) Synthesis of deuterated morpholine derivatives
JP2015501276A5 (enExample)
JP2016513122A5 (enExample)
HRP20100260T1 (hr) Postupak za proizvodnju stroncij ranelata i njegovih hidrata
RU2013137753A (ru) Твердые формы ингибитора гиразы (r)-1-этил-3-[5-[2-(1-гидрокси-1-метилэтил)пиримидин-5-ил]-7-(тетрагидрофуран-2-ил)-1н-бензимидазол-2-ил]мочевины
RU2016101630A (ru) Кристаллические формы свободного основания
RU2012128887A (ru) Способ получения гидрохлорида моксифлоксацина и его промежуточных продуктов
WO2009047499A3 (en) Processes for the preparation of paliperidone and pharmaceutically acceptable salts thereof and intermediates for use in the processes
RU2019131147A (ru) Новые хиназолиноновые производные, ингибирующие pi3k, и содержащая их фармацевтическая композиция
RU2017118432A (ru) СПОСОБЫ И ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ ДЛЯ ПОЛУЧЕНИЯ ДИАЛКАНОВЫХ ЭФИРОВ, СОДЕРЖАЩИХ КОНЦЕВУЮ α,ω-ДИКАРБОНОВОКИСЛОТНУЮ ГРУППУ
MA39715A (fr) Formes polymorphes de l'acide 4,5-dihydro-1h-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylique et de son sel de disodium, procédé de préparation desdites formes polymorphes et leur utilisation
ES2456866T3 (es) Procedimiento para la obtención de 3,3-difenilpropilaminas
JP2013227563A5 (enExample)